Changes in Rimazolen Dosage in Insomnia Patients Undergoing Digestive Endoscopy
NCT07028190 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 840
Last updated 2025-09-10
Summary
To compare the dosage requirement of rimazolen during digestive endoscopy between patients with insomnia and those with normal sleep pattern.
Conditions
- Insomnia
- Digestive Endoscopy
Interventions
- OTHER
-
No interventions, it is a observational study
No interventions, this study is to compare the dosage requirement of ciprofol during digestive endoscopy between insomnia group and normal sleep group.
Sponsors & Collaborators
-
Daxing Teaching Hospital, Capital Medical University
collaborator UNKNOWN -
Hebei Medical University Third Hospital
collaborator OTHER -
Hengshui People's Hospital
collaborator OTHER -
Beijing Tiantan Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-12
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
Countries
- China
Study Locations
More Related Trials
-
A Study of Ramelteon in Chinese Patients With Chronic Insomnia
NCT06512363 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Correlation Study of Hypnotic Drugs on the Cognitive Function of Patients With Chronic Insomnia.
NCT04996953 ·Status: UNKNOWN
-
A Study of Lemborexant in Chinese Participants With Insomnia Disorder
NCT04549168 ·Status: COMPLETED ·Phase: PHASE3
-
Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia
NCT05289518 ·Status: UNKNOWN ·Phase: NA
-
Modified Suanzaoren Decoction Versus Eszopiclone for the Treatment of Chronic Insomnia Disorder
NCT06452953 ·Status: COMPLETED ·Phase: NA
-
Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty
NCT02058992 ·Status: COMPLETED
-
FMT for Insomnia Disorder (FMT-SLEEP)
NCT06606938 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly
NCT02648776 ·Status: UNKNOWN
-
A Study of Daridorexant in Chinese Patients With Insomnia Disorder
NCT06010693 ·Status: COMPLETED ·Phase: PHASE3
-
Chinese Medicine in Treating Insomnia
NCT06511011 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.
NCT00414102 ·Status: COMPLETED ·Phase: PHASE4
-
Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder
NCT06279286 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
DexmedetOmidine Complement Treats Chronic insOmnia and Improves Circadian Rhythm (DOCTOR)
NCT04635098 ·Status: COMPLETED ·Phase: NA
-
FMT Capsules in Treatment of Patients With Insomnia Clinical Research
NCT05427331 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Ramelteon on Chronic Insomnia
NCT00915135 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia
NCT00748592 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intranasal Dexmedetomidine and Zolpidem for Treatment of Primary Insomnia
NCT05615727 ·Status: UNKNOWN ·Phase: PHASE3
-
The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy
NCT02669082 ·Status: COMPLETED ·Phase: PHASE4
-
Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients.
NCT00347295 ·Status: COMPLETED ·Phase: PHASE3
-
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
NCT00606593 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia
NCT03461042 ·Status: COMPLETED ·Phase: PHASE4
-
Study for Evaluating the Efficacy of Ciprofol in Patients Under Narcotic Sleep With Chronic Insomnia
NCT04958382 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia
NCT00756002 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder
NCT02350309 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274
NCT02852395 ·Status: COMPLETED ·Phase: PHASE1